Alvaro Francisco Torres

Alvaro Francisco Torres discloses dealings in Khiron Life Sciences Corp. to SEDI. We count 14 filings; the first trade dates from 16 May 2018 and the latest from 10 June 2022.

Purchases make up the whole of the open-market record (7 purchases, €82k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 3 option exercises.

In size, the median ticket on the buying side is €9,971. None of the 6 purchases we analysed coincided with buying by another insider of the same company within 30 days.

On 14 June 2022 came the latest disclosure, a transaction for €44k in Khiron Life Sciences Corp. The latest purchase dates back some time: it was published 1,767 days ago, on 22 December 2021. Filings reach the SEDI feed a median of 3 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.